Literature DB >> 20100873

Production of a class II two-component lantibiotic of Streptococcus pneumoniae using the class I nisin synthetic machinery and leader sequence.

Joanna A Majchrzykiewicz1, Jacek Lubelski, Gert N Moll, Anneke Kuipers, Jetta J E Bijlsma, Oscar P Kuipers, Rick Rink.   

Abstract

Recent studies showed that the nisin modification machinery can successfully dehydrate serines and threonines and introduce lanthionine rings in small peptides that are fused to the nisin leader sequence. This opens up exciting possibilities to produce and engineer larger antimicrobial peptides in vivo. Here we demonstrate the exploitation of the class I nisin production machinery to generate, modify, and secrete biologically active, previously not-yet-isolated and -characterized class II two-component lantibiotics that have no sequence homology to nisin. The nisin synthesis machinery, composed of the modification enzymes NisB and NisC and the transporter NisT, was used to modify and secrete a putative two-component lantibiotic of Streptococcus pneumoniae. This was achieved by genetically fusing the propeptide-encoding sequences of the spr1765 (pneA1) and spr1766 (pneA2) genes to the nisin leader-encoding sequence. The chimeric prepeptides were secreted out of Lactococcus lactis, purified by cation exchange fast protein liquid chromatography, and further characterized. Mass spectrometry analyses demonstrated the presence and partial localization of multiple dehydrated serines and/or threonines and (methyl)lanthionines in both peptides. Moreover, after cleavage of the leader peptide from the prepeptides, both modified propeptides displayed antimicrobial activity against Micrococcus flavus. These results demonstrate that the nisin synthetase machinery can be successfully used to modify and produce otherwise difficult to obtain antimicrobially active lantibiotics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20100873      PMCID: PMC2849381          DOI: 10.1128/AAC.00883-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  43 in total

1.  The flavoprotein MrsD catalyzes the oxidative decarboxylation reaction involved in formation of the peptidoglycan biosynthesis inhibitor mersacidin.

Authors:  Florian Majer; Dietmar G Schmid; Karsten Altena; Gabriele Bierbaum; Thomas Kupke
Journal:  J Bacteriol       Date:  2002-03       Impact factor: 3.490

2.  Each peptide of the two-component lantibiotic lacticin 3147 requires a separate modification enzyme for activity.

Authors:  Olivia McAuliffe; Colin Hill; R Paul Ross
Journal:  Microbiology (Reading)       Date:  2000-09       Impact factor: 2.777

Review 3.  Nonlantibiotic antibacterial peptides from lactic acid bacteria.

Authors:  M J van Belkum; M E Stiles
Journal:  Nat Prod Rep       Date:  2000-08       Impact factor: 13.423

4.  The structure of nisin.

Authors:  E Gross; J L Morell
Journal:  J Am Chem Soc       Date:  1971-09-08       Impact factor: 15.419

Review 5.  Developing applications for lactococcal bacteriocins.

Authors:  R P Ross; M Galvin; O McAuliffe; S M Morgan; M P Ryan; D P Twomey; W J Meaney; C Hill
Journal:  Antonie Van Leeuwenhoek       Date:  1999 Jul-Nov       Impact factor: 2.271

6.  Genome of the bacterium Streptococcus pneumoniae strain R6.

Authors:  J Hoskins; W E Alborn; J Arnold; L C Blaszczak; S Burgett; B S DeHoff; S T Estrem; L Fritz; D J Fu; W Fuller; C Geringer; R Gilmour; J S Glass; H Khoja; A R Kraft; R E Lagace; D J LeBlanc; L N Lee; E J Lefkowitz; J Lu; P Matsushima; S M McAhren; M McHenney; K McLeaster; C W Mundy; T I Nicas; F H Norris; M O'Gara; R B Peery; G T Robertson; P Rockey; P M Sun; M E Winkler; Y Yang; M Young-Bellido; G Zhao; C A Zook; R H Baltz; S R Jaskunas; P R Rosteck; P L Skatrud; J I Glass
Journal:  J Bacteriol       Date:  2001-10       Impact factor: 3.490

7.  Mechanistic dissection of the enzyme complexes involved in biosynthesis of lacticin 3147 and nisin.

Authors:  Anneke Kuipers; Jenny Meijer-Wierenga; Rick Rink; Leon D Kluskens; Gert N Moll
Journal:  Appl Environ Microbiol       Date:  2008-09-12       Impact factor: 4.792

8.  Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model.

Authors:  Danuta Kruszewska; Hans-Georg Sahl; Gabriele Bierbaum; Ulrike Pag; Sean O Hynes; Asa Ljungh
Journal:  J Antimicrob Chemother       Date:  2004-07-28       Impact factor: 5.790

9.  SpaC and NisC, the cyclases involved in subtilin and nisin biosynthesis, are zinc proteins.

Authors:  Nicole M Okeley; Moushumi Paul; Jay P Stasser; Ninian Blackburn; Wilfred A van der Donk
Journal:  Biochemistry       Date:  2003-11-25       Impact factor: 3.162

10.  NisT, the transporter of the lantibiotic nisin, can transport fully modified, dehydrated, and unmodified prenisin and fusions of the leader peptide with non-lantibiotic peptides.

Authors:  Anneke Kuipers; Esther de Boef; Rick Rink; Susan Fekken; Leon D Kluskens; Arnold J M Driessen; Kees Leenhouts; Oscar P Kuipers; Gert N Moll
Journal:  J Biol Chem       Date:  2004-03-24       Impact factor: 5.157

View more
  36 in total

Review 1.  Genome mining for ribosomally synthesized natural products.

Authors:  Juan E Velásquez; Wilfred A van der Donk
Journal:  Curr Opin Chem Biol       Date:  2010-11-20       Impact factor: 8.822

2.  Increasing the Antimicrobial Activity of Nisin-Based Lantibiotics against Gram-Negative Pathogens.

Authors:  Qian Li; Manuel Montalban-Lopez; Oscar P Kuipers
Journal:  Appl Environ Microbiol       Date:  2018-05-31       Impact factor: 4.792

Review 3.  Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes.

Authors:  Lindsay M Repka; Jonathan R Chekan; Satish K Nair; Wilfred A van der Donk
Journal:  Chem Rev       Date:  2017-01-30       Impact factor: 60.622

Review 4.  Bacteriocins - a viable alternative to antibiotics?

Authors:  Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Nat Rev Microbiol       Date:  2012-12-24       Impact factor: 60.633

5.  Lantibiotics from Geobacillus thermodenitrificans.

Authors:  Neha Garg; Weixin Tang; Yuki Goto; Satish K Nair; Wilfred A van der Donk
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

6.  Further Identification of Novel Lantibiotic Operons Using LanM-Based Genome Mining.

Authors:  Orla O'Sullivan; Máire Begley; R Paul Ross; Paul D Cotter; Colin Hill
Journal:  Probiotics Antimicrob Proteins       Date:  2011-03       Impact factor: 4.609

7.  Characterization of Leader Peptide Binding During Catalysis by the Nisin Dehydratase NisB.

Authors:  Lindsay M Repka; Kenton J Hetrick; See Hyun Chee; Wilfred A van der Donk
Journal:  J Am Chem Soc       Date:  2018-03-20       Impact factor: 15.419

8.  Pseudomycoicidin, a Class II Lantibiotic from Bacillus pseudomycoides.

Authors:  Shradha Basi-Chipalu; Jasmin Dischinger; Michaele Josten; Christiane Szekat; Annegret Zweynert; Hans-Georg Sahl; Gabriele Bierbaum
Journal:  Appl Environ Microbiol       Date:  2015-03-13       Impact factor: 4.792

9.  Evolution of lanthipeptide synthetases.

Authors:  Qi Zhang; Yi Yu; Juan E Vélasquez; Wilfred A van der Donk
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

10.  Discovery of a novel lantibiotic nisin O from Blautia obeum A2-162, isolated from the human gastrointestinal tract.

Authors:  Diane Hatziioanou; Cristina Gherghisan-Filip; Gerhard Saalbach; Nikki Horn; Udo Wegmann; Sylvia H Duncan; Harry J Flint; Melinda J Mayer; Arjan Narbad
Journal:  Microbiology (Reading)       Date:  2017-08-31       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.